OpenURL Connection Search

Select item for more details and to access through your institution.

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.
Published in:
Investigational New Drugs, 2018, v. 36, n. 4, p. 683, doi. 10.1007/s10637-018-0580-2
By:
- Hurwitz, Herbert;
- Van Cutsem, Eric;
- Bendell, Johanna;
- Hidalgo, Manuel;
- Li, Chung-Pin;
- Salvo, Marcelo Garrido;
- Macarulla, Teresa;
- Sahai, Vaibhav;
- Sama, Ashwin;
- Greeno, Edward;
- Yu, Kenneth H.;
- Verslype, Chris;
- Dawkins, Fitzroy;
- Walker, Chris;
- Clark, Jason;
- O’Reilly, Eileen M.
Publication type:
Article
Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: A veterans' affairs central cancer registry (VACCR) database analysis.
Published in:
Journal of Surgical Oncology, 2011, v. 104, n. 6, p. 667, doi. 10.1002/jso.21886
By:
- Gonsalves, Wilson I;
- Kanuri, Swapna;
- Tashi, Tsewang;
- Aldoss, Ibrahim;
- Sama, Ashwin;
- Al-Howaidi, Islam;
- Ganta, Ashwin;
- Kalaiah, Mudappa;
- Thota, Ramya;
- Krishnamurthy, Jairam;
- Fang, Xiang;
- Townley, Peter;
- Ganti, Apar K.;
- Subbiah, Shanmuga;
- Silberstein, Peter T.
Publication type:
Article
First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.
Published in:
Oncologist, 2019, v. 24, n. 9, p. e930, doi. 10.1634/theoncologist.2018-0411
By:
- He, Aiwu Ruth;
- Cohen, Roger B.;
- Denlinger, Crystal S.;
- Sama, Ashwin;
- Birnbaum, Ariel;
- Hwang, Jimmy;
- Sato, Takami;
- Lewis, Nancy;
- Mynderse, Michelle;
- Niland, Michele;
- Giles, Jennifer;
- Wallin, Johan;
- Moser, Brian;
- Zhang, Wei;
- Walgren, Richard;
- Plimack, Elizabeth R.
Publication type:
Article
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.
Published in:
Oncologist, 2016, v. 21, n. 11, p. 1296, doi. 10.1634/theoncologist.2016-0297
By:
- Lin, Jianqing;
- Patel, Sheel A.;
- Sama, Ashwin R.;
- Hoffman‐Censits, Jean H.;
- Kennedy, Brooke;
- Kilpatrick, Deborah;
- Ye, Zhong;
- Yang, Hushan;
- Mu, Zhaomei;
- Leiby, Benjamin;
- Lewis, Nancy;
- Cristofanilli, Massimo;
- Kelly, William Kevin
Publication type:
Article
Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.
Published in:
International Journal of Women's Health, 2014, v. 6, p. 149, doi. 10.2147/IJWH.S40889
By:
- Sama, Ashwin R.;
- Schilder, Russell J.
Publication type:
Article

Found: 5

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.

Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: A veterans' affairs central cancer registry (VACCR) database analysis.

First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.

A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.

Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.